The Mölnlycke, Biogel and Indicator trademarks, names, and logo types are registered globally to one or more of the Mölnlycke Health Care Group of
Companies. Distributed by Mölnlycke Health Care US, LLC, 5550 Peachtree Pkwy # 500, Norcross, Georgia 30092 © 2019 Mölnlycke Health Care AB.
All rights reserved. MHC-2019-37587
1. MHC Study #G09-005. 2. Scott,Douglas R II. The Direct Costs of Healthcare-
Associated Infections In U.S. Hospitals and the Benefits of Prevention, March 2009
3. Misteli H, et al Surgical glove Perforation and the Risk of Surgical Site Infection. Arch
Surg. 2009; 144(6);553-558. 4. Data on File, MHC-2018-T00015.
Glove perforations can increase the risk of surgical site infections
(SSIs) to 6.9%.
3
Biogel gloves are clinically proven to reduce glove
failures, helping protect surgeons and staff from injury, patients from
SSIs and saving hospitals thousands of dollars in related costs.
1, 4
TELL YOUR HOSPITAL YOU NEED BIOGEL.
www.molnlycke.us/ChooseBiogel
CHOOSE
Biogel lowers the risk of SSIs
• 3.5 times fewer glove failures than competitive gloves
1
• $56 in SSI related savings per surgery
1, 2
ANY OTHER GLOVE IS
TOO BIG A RISK.
